methylprednisolone has been researched along with Mast Cell Activation Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, H; Igarashi, Y; Kanbe, N; Kurimoto, F; Kurosawa, M; Miyachi, Y; Nagata, H; Yamashita, T | 1 |
| Hanna, P; López, A; McConkey, S; Spracklin, D | 1 |
2 other study(ies) available for methylprednisolone and Mast Cell Activation Disease
| Article | Year |
|---|---|
Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis.
Topics: Bone Marrow Cells; Chymases; Cyclosporine; Dose-Response Relationship, Drug; Hematologic Tests; Histamine Release; Humans; Inflammation Mediators; Karyotyping; Male; Mast Cells; Mastocytosis; Methylprednisolone; Middle Aged; Serine Endopeptidases; Tryptases | 1999 |
Cutaneous mucinosis and mastocytosis in a shar-pei.
Topics: Animals; Azathioprine; Dog Diseases; Dogs; Euthanasia; Fatal Outcome; Female; Immunosuppressive Agents; Mastocytosis; Methylprednisolone; Methylprednisolone Acetate; Mucinoses | 1999 |